Characterization and evaluation of a new oncolytic Vaccinia Virus strain LIVP6.1.1 for canine cancer therapy

Virotherapy on the basis of oncolytic vaccinia virus (VACV) strains is one novel approach for canine cancer therapy. In this study we described for the first time the characterization and the use of new VACV strain LIVP6.1.1 as an oncolytic agent against canine cancer in a panel of four canine cance...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Gentschev, Ivaylo, Patil, Sandeep S., Adelfinger, Marion, Weibel, Stephanie, Geissinger, Ulrike, Frentzen, Alexa, Chen, Nanhai G., Yu, Yong A., Zhang, Qian, Ogilvie, Gregory, Szalay, Aladar A.
Formato: Artigo
Idioma:Inglês
Publicado: Landes Bioscience 2013
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3609626/
https://ncbi.nlm.nih.gov/pubmed/23093804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/bioe.22462
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares